SHINICHIRO OHSHIMO

Last Updated :2019/04/09

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), ., Associate Professor
Web Site
E-mail
ohshimoshiroshima-u.ac.jp
Other Contact Details
1-2-3,Kasumi,Minami-ku,Hiroshima, Japan
TEL : (+81)81-82-257-5 FAX : (+81)
Self-introduction
My research field is the emergency and critical care medicine, predominantly acute respiratory failure and sepsis. My specialty is the acute exacerbation of idiopathic pulmonary fibrosis and the extracorporeal membrane oxygenation (ECMO).

Basic Information

Major Professional Backgrounds

  • 2008/04/01, 2009/03/31, Department of Respiratory Medicine, Hiroshima University Hospital, Research associate
  • 2009/04/01, 2014/03/31, Department of Intensive Care Medicine, Hiroshima University Hospital, Research Associate
  • 2014/04/01, 2017/03/31, Advanced Emergency and Critical Care Center, Hiroshima University Hospital, Associate Professor or Lecturer
  • 2017/04/01, Department of Emergency and Critical Care Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University, Associate Professor

Academic Degrees

  • MD, PhD, Hiroshima University

Educational Activity

  • School of Medicine:Program of Medicine, Graduate School of Biomedical & Health Sciences:Biomedical Sciences Major

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Emergency medicine

Research Keywords

  • acute respiratory failure
  • interstitial lung diseases; idiopathic pulmonary fibrosis
  • extracorporeal membrane oxygenation; ECMO
  • sepsis
  • Mechanical ventilation

Affiliated Academic Societies

  • Japanese Association for Acute Medicine
  • Japanese Society of Intensive Care Medicine
  • Japanese Society of Internal Medicine
  • Japanese Respiratory Society
  • Japan Society of Respiratory Care Medicine
  • Japan Society for Respiratory Endoscopy
  • American Thoracic Society
  • European Respiratory Society
  • World Association for Sarcoidosis and Other Granulomatous Disorders
  • Japan Society for Blood Purification in Critical Care
  • Japanese Society of Reanimatology

Educational Activity

Course in Charge

  1. 2019, Undergraduate Education, Intensive, Systemic Disease Control
  2. 2019, Undergraduate Education, Intensive, Symptomatology, Diagnosis and Treatment
  3. 2019, Undergraduate Education, 4Term, Emergency and Critical Care Medicine

Award of Education

  1. 2017/09/22, Hiroshima University

Research Activities

Academic Papers

  1. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts, 20051201
  2. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 338(4), 1845-1852, 20051230
  3. Bronchoalveolar lavage in other interstitial lung diseases, 20071001
  4. Circulating KL-6/MUC1 mucin carrying sialyl Lewis(a) oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma, INTERNATIONAL JOURNAL OF CANCER, 120(12), 2643-2649, 20070615
  5. Usefulness monitoring of circulating KL-6 in patients with advanced non-small cell lung cancers treated with gefitinib therapy., International journal of cancer, 122(11), 2612-2620, 20080601
  6. Diagnosis of sarcoidosis, 20080901
  7. Esophageal sarcoidosis presenting as pseudodiverticulum, 20080901
  8. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors, INTERNATIONAL JOURNAL OF CANCER, 122(11), 2612-2620, 20080601
  9. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis., Am J Respir Crit Care Med, 179(11), 1043-1047, 20090601
  10. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis, 20090601
  11. Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis, 20090701
  12. Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease, 20091001
  13. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET, 20100801
  14. Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy., Cancer Chemother Pharmacol, 67(6), 1465-9, 20110101
  15. Phase I study docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer., Oncology Letters, 2, 167-170, 20110101
  16. Regresson of a primary pulmonary adenocarcinoma after zoledronic acid monotherapy., Hiroshima J. Med. Sci, 60(1), 7-9, 20110301
  17. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement, 20110701
  18. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation, 20110801
  19. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation., J Heart Lung Transplant, 30(12), 1374-1380, 20110801
  20. Pulmonary alveolar proteinosis: New insights from a single-center cohort of 70 patients, 20110901
  21. Pulmonary alveolar proteinosis: New insights from a single-center cohort of 70 patients, RESPIRATORY MEDICINE, 105(12), 1908-1916, 201112
  22. Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer, ONCOLOGY LETTERS, 2(1), 167-170, 2011
  23. SURFACTANT PROTEIN D AND KL-6 SERUM LEVELS IN SYSTEMIC SCLEROSIS: CORRELATION WITH LUNG AND SYSTEMIC INVOLVEMENT, SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 28(1), 27-33, 201107
  24. Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67(6), 1465-1469, 201106
  25. KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome, ORPHANET JOURNAL OF RARE DISEASES, 7, 20121217
  26. Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels, RESPIRATORY MEDICINE, 106(12), 1756-1764, 201212
  27. Hypersensitivity Pneumonitis, IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 32(4), 537-+, 201211
  28. Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis, ORPHANET JOURNAL OF RARE DISEASES, 8, 20130404
  29. Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms, BMC MEDICAL GENETICS, 15, 20140108
  30. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis, RESPIRATORY MEDICINE, 108(7), 1031-1039, 201407
  31. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis, RESPIROLOGY, 20(3), 439-444, 2015
  32. A pilot study: a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute exacerbation of interstitial pneumonia., Sarcoidosis Vasc Diffuse Lung Dis, 31(4), 343-349, 2015
  33. Exploring causative pathology is essential for validating harmful effects of late intubation, Crit Care Med, (in press), 2016
  34. MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis., Orphanet J Rare Dis, 11, 48-48, 2016
  35. Long-term pulmonary complications of chemical weapons exposure in former poison gas factory workers., Inhal Toxicol, (in press), 2016
  36. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis., Dis Markers, (in press), 2016
  37. Exploring potential co-factors affecting coagulation and inflammation activity during extracorporeal membrane oxygenation, Crit Care Med, (in press), 2016
  38. Are probiotics actually useful in decreasing VAP rate?, Intensive Care Med, (in press), 2016
  39. Influencing factor of biomarkers of endothelial and alveolar epithelial dysfunction, Intensive Care Med, (in press), 2016
  40. Is transpulmonary pressure-guided PEEP titration really optimal?, Intensive Care Med, (in press), 2016
  41. Potential covariates that affect post-extubation breathing effort in children., Intensive Care Med, (in press), 2016
  42. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis, Eur Respir J, (in press), 2016
  43. Pediatric cardiorespiratory failure successfully managed with venoarterial-venous extracorporeal membrane oxygenation, BMC Pulm Med, 16, 20160812
  44. Pediatric cardiorespiratory failure successfully managed with venoarterial-venous extracorporeal membrane oxygenation: a case report, BMC PULMONARY MEDICINE, 16, 20160812
  45. Innovation in Respiratory Sound Analysis, Ann Intern Med, 164(9), 638-639, 201603
  46. FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis, RESPIRATORY MEDICINE, 123, 105-109, 201702
  47. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis, EUROPEAN RESPIRATORY JOURNAL, 49(2), 201702
  48. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis, RESPIROLOGY, 22(5), 965-971, 201707
  49. The clinical practice guideline for the management of ARDS in Japan, JOURNAL OF INTENSIVE CARE, 5, 20170725
  50. Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets, BMC MEDICAL GENETICS, 18, 20170818
  51. CLINICAL AND MOLECULAR FEATURES OF RAPIDLY PROGRESSIVE CHRONIC HYPERSENSITIVITY PNEUMONITIS, SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 34(1), 48-57, 2017
  52. Differential diagnosis of granulomatous lung disease: clues and pitfalls, EUROPEAN RESPIRATORY REVIEW, 26(145), 201709
  53. AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma, ONCOTARGET, 8(55), 94382-94392, 20171107
  54. Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis, RESPIROLOGY, 22(7), 1371-1378, 201710
  55. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 81(1), 131-139, 201801
  56. Comparison of extracorporeal membrane oxygenation outcome for influenza-associated acute respiratory failure in Japan between 2009 and 2016, JOURNAL OF INTENSIVE CARE, 6, 20180711
  57. Potential Confounders of the Accuracy and Reliability of Delirium Assessment Tools, Crit Care Med, 45(1), e114, 2017
  58. Outcome Prediction for Acute Respiratory Distress Syndrome: Are the Current Three Variables Really Optimal?, Crit Care Med, 45(2), e237-e238, 2017
  59. Is Higher Cerebral Oxygen Saturation Really Predictive of Favorable Neurologic Outcome After In-Hospital Cardiac Arrest?, Crit Care Med, 45(4), e468-e469, 2017
  60. MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study., BMC Cancer, 17(1), 263-263, 2017
  61. Next Step to Understanding Subphenotypes of Acute Respiratory Distress Syndrome, Am J Respir Crit Care Med, 196(6), 795-796, 2017
  62. Optimal Cutoff Value for Lung Injury Prediction Score and Potential Confounders for Identifying the Risk of Developing Acute Respiratory Distress Syndrome, Crit Care Med, 45(6), e624-e625, 2017
  63. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study, Eur Respir J, 50(2), pii: 1700936-pii: 1700936, 2017
  64. Combined rupture of left ventricular free wall and pericardium, Intensive Care Med, 43(12), 1858-1859, 2017
  65. Potential factors affecting lung inhomogeneity in acute respiratory distress syndrome., Intensive Care Med, 44(1), 125-126, 2018
  66. Does enhanced antibiotic de-escalation really have no benefit in the ICU?, Crit Care, 21(1), 270-270, 2017
  67. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer, Cancer Chemother Pharmacol, 81(1), 131-139, 2018
  68. Confounders Affecting the Prognosis in Patients With Acute Decompensated Heart Failure Who Underwent Extracorporeal Membrane Oxygenation, Crit Care Med, 45(12), e1309-e1309, 2017
  69. Potential Confounders of Procalcitonin-Guided Antibiotic Therapy for Sepsis, Crit Care Med, 45(12), e1310-e1311, 2017
  70. Is Oxygenation Really an Intrinsic Predictive Factor of Mortality in Patients Undergoing Extracorporeal Life Support?, Crit Care Med, 46(2), e181-e182, 2018
  71. Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy, Intensive Care Med, 44(3), 399-400, 2018
  72. Accurate Quantification of Pleural Effusion and Cofactors Affecting Weaning Failure, Anesthesiology, 128(3), 678-679, 2018
  73. Potential confounders affecting the reintubation rate : Discussion on "Reconnection to mechanical ventilation for 1 h after a successful spontaneous breathing trial reduces reintubation in critically ill patients: a multicenter randomized controlled trial", Intensive Care Med, 44(4), 542-543, 2018
  74. Target blood pressure for septic and vasodilatory shock: what is optimal?, Intensive Care Med, 44(4), 548-549, 2018
  75. An emerging frontier in the treatment of acute exacerbation of idiopathic pulmonary fibrosis, Respir Investig, 56(2), 97-99, 2018
  76. Use of proton pump inhibitors is associated with increased mortality due to nosocomial pneumonia in bedridden patients receiving tube feeding, Geriatr Gerontol Int, 18(8), 1215-1218, 2018
  77. Rapid-onset plasma leakage of extracorporeal oxygenation membranes possibly due to hyperbilirubinemia, J Artif Organs, (in press), 2018
  78. Does Dysphagia After Extubation Really Increase Mortality?, Crit Care Med, 46(7), e726-e727, 2018
  79. Comparison of extracorporeal membrane oxygenation outcome for influenza-associated acute respiratory failure in Japan between 2009 and 2016, J Intensive Care, 11(6), 38-38, 2018
  80. Should We Abandon APRV in Pediatric ARDS?, Am J Respir Crit Care Med, (in press), 2018
  81. Use of proton pump inhibitors is associated with increased mortality due to nosocomial pneumonia in bedridden patients receiving tube feeding, GERIATRICS & GERONTOLOGY INTERNATIONAL, 18(8), 1215-1218, 201808
  82. 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary, Resuscitation, S0300-9572(18), 31001-31003, 2018
  83. 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary, Circulation, 2018
  84. Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients., Transpl Immunol, S0966-3274(18), 30082-30090, 2018
  85. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study., Lancet Respir Med, S2213-2600(18), 30344-30348, 2018
  86. Focusing on Risk Factors of Cardiac Arrest During Intubation in ICU Again., Crit Care Med, 46(11), e1082-e1082, 2018
  87. The western Japan chaotic rainstorm disaster – A brief report from Hiroshima, J Intensive Care, 2018

Publications such as books

  1. 2016, 呼吸器ケア, "肺にやさしい換気"がわかる 人工呼吸管理中のモニタリングシステム, メディカ出版, 2016, 2016
  2. 2016, 日本外科感染症学会雑誌, 誤嚥と誤嚥性肺炎について考える, 日本外科感染症学会, 2016, 2016
  3. 2016, 救急・集中治療, 中心静脈カテーテル抜去時のカテーテル培養をルーチンで行う?, 総合医学社, 2016, 2016

Invited Lecture, Oral Presentation, Poster Presentation

  1. KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis, Ohshimo S, European Respiratory Society, 2009, Without Invitation
  2. 特発性間質性肺炎の日本・ヨーロッパ比較研究, Ohshimo S, 第50回日本呼吸器学会学術講演会, 2009, Without Invitation
  3. Serum High-density Lipoprotein Cholesterol as a Prognostic Factor for Lung Cancer, Ohshimo S, The 19th International Symposium of Hiroshima Cancer Seminar, 2009, Without Invitation
  4. Serial change in serum KL-6 levels correlate with the pulmonary function variables in cystic fibrosis, Ohshimo S, 2010 ERS Annual Congress, 2010, Without Invitation
  5. KL-6, a Human MUC1 Mucin, as a Prognostic Factor for Diffuse Alveolar Hemorrhage Syndrome, Ohshimo S, 2010, Without Invitation
  6. びまん性肺胞出血症候群の;予後因子の検討, Ohshimo S, 第38回 日本救急医学会総会・学術集会, 2010, Without Invitation
  7. HFOVによる呼吸管理が有用であった閉塞性気管支炎の一例, Ohshimo S, 第32回日本呼吸療法医学会学術総会, 2010, Without Invitation
  8. Serum Levels of KL-6, a Biomarker for Interstitial Lung Diseases, in Caucasian Patients with Idiopathic Interstitial Pneumonias, Ohshimo S, 2010 ATS International Conference, 2010, Without Invitation
  9. Serum KL-6 Levels Are Associated With Long-Term Prognosis in Lung Transplant Recipients, Vasilliki Bessa, Shinichiro Ohshimo, Gerhard Weinreich , Francesco Bonella, Ulrich Costabel, Markus Kamler, Helmut Teschler, Urte Sommerwerck, International Society for Heart & Lung Transplantation 34th Annual Meeting, 2014, Without Invitation
  10. Sedation and Muscle Relaxation in HFO, Shinichiro Ohshimo, High-frequency Oscillation (HFO) Experts Conference, 2014, With Invitation
  11. 当院での敗血症性ショックに対するエンドトキシン吸着療法(PMX-DHP)の検討, 板井純治, 廣橋伸之,儀賀普嗣,稲川嵩紘,木田佳子,太田浩平,大谷直嗣,貞森拓磨,宇根一暢,大下慎一郎,津村龍,岩崎泰昌,谷川攻一, 第18回 エンドトキシン血症救命治療研究会, 2014/01, Without Invitation
  12. 熱傷ショックにたこつぼ型心筋症を合併した高齢者熱傷の1例, 岩崎泰昌, 宇根一暢,太田浩平,大下慎一郎,稲川嵩紘,大谷直嗣,板井純治,木田佳子,廣橋伸之,谷川攻一, 第41回 日本集中治療医学会学術集会, 2014/01, Without Invitation
  13. ECMOを用いた重症呼吸不全治療における当院の取り組み, Ohshimo S, 第41回 日本集中治療医学会学術集会, 2014/02, With Invitation
  14. Prevention of pneumothorax using veno-venous ECMO in acute respiratory distress syndrome with emphysematous/cystic changes in the lung, Tadatsugu Otani, Shinichiro Ohshimo, Kohei Ota, Yoshiko Kida, Takahiro Inagawa, Junji Itai, Satoshi Yamaga, Kazunobu Une, Yasumasa Iwasaki, Nobuyuki Hirohashi, Nobuoki Kohno, Koichi Tanigawa, 34 th International Symposium on Intensive Care and Emergency Medicine, 2014/03/18, Without Invitation
  15. Serum KL-6 Ausgangskonzentration korreliert mit der Langzeitprognose von lungentransplantierten Patienten, V. Bessa, S. Ohshimo, G. Weinreich , F. Bonella, U.Costabel, M. Kamler, H. Teschler, U. Sommerwerck, 55. Kongress der Deutschen Gesellschaft für Pathologie und Beatmungsmedizin, 2014/03/26, Without Invitation, Bremen, Germany
  16. 急性呼吸不全におけるWearable-ECMO開発への取組み, Ohshimo S, 第54回 日本呼吸器学会学術講演会, 2014/04, Without Invitation
  17. Impact of Ethnic Difference and TERT Gene Polymorphisms in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis, Shinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Francesco Bonella, Josune Guzman, Ulrich Costabel, Nobuoki Kohno, 第54回 日本呼吸器学会学術講演会, 2014/04, Without Invitation
  18. 若手医師に役立つ実戦講座「呼吸管理のスタンダードから」:人工呼吸管理の羅針盤~ゴールデンスタンダードを求めて~ 新しいモニターシステム・画像・血清マーカー, Ohshimo S, 第54回 日本呼吸器学会学術講演会, 2014/04, With Invitation
  19. 若者への留学の奨め-留学体験報告:ドイツ人とともに生活して見えてきたもの, Ohshimo S, 第54回 日本呼吸器学会学術講演会, 2014/04, With Invitation
  20. Bubble like appearanceを呈する肺腺癌における気管支鏡検査の有用性, 濱井宏介, 石川暢久, 中島 拓, 岩本博志, 妹尾 直, 大下慎一郎, 藤高一慶, 春田吉則, 濱田泰伸, 村井 博, 服部 登, 河野修興, 第37回 日本呼吸器内視鏡学会学術集会, 2014/04, Without Invitation
  21. Impact of Ethnic Difference and TERT Gene Polymorphisms in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis, Shinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Francesco Bonella, Josune Guzman, Ulrich Costabel, Nobuoki Kohno, American Thoracic Society International Conference 2014. San Diego, California, USA, 2014/05, Without Invitation
  22. Serum CCL-18 may predict the short-term response to pirfenidone in idiopathic pulmonary fibrosis, Bonella Francesco, Costabel Ulrich, He Xuan, Ohshimo Shinichiro, Guzman Josune, Thomas E Wessendorf, ATS 2014 International Conference, 2014/05, Without Invitation, San Diego, California
  23. Annual decline in lung function can predict the prognosis of patients with chronic hypersensitivity pneumonia, Yasushi Horimasu, Nobuhisa Ishikawa, Taku Nakashima, Hiroshi Iwamoto, Tadashi Seno, Shinichiro Ohshimo, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Nobuoki Kohno, ATS 2014 International Conference, 2014/05, Without Invitation, San Diego, California
  24. Gene expression profiles of idiopathic interstitial pneumonias: Molecular signatures of pulmonary fibrosis, Nobuhisa Ishikawa, Takeshi Masuda, Yasushi Horimasu, Noboru Hattori, Shinichiro Ohshimo, Nobuoki Kohno, ATS 2014 International Conference, 2014/05, Without Invitation, San Diego, California
  25. 人工呼吸器関連肺炎の 新しい判定基準:VAE, Ohshimo S, 国公立大学附属病院感染対策協議会中国四国ブロック別研修会, 2014/05, With Invitation
  26. 広島県ドクターヘリの現状と取り組み, 大谷直嗣, 宇根一暢,津村龍,太田浩平,山賀聡之,鈴木 慶,田村朋子,貞森拓磨,大下慎一郎,岩崎泰昌,廣橋伸之,多田昌弘,佐伯辰彦,板井純治,竹崎 亨,楠 真二,山野上敬夫,谷川攻一, 第30回 日本救急医学会 中国四国地方会, 2014/05, Without Invitation
  27. ARDS に対する換気様式の選択:高頻度振幅換気(HFOV)が有効なARDS患者をいかに選択するか, Ohshimo S, 第36回 日本呼吸療法医学会学術総会, 2014/07, Without Invitation
  28. ECMOプロジェクト教育講演:VV-ECMO管理中に腸腰筋出血をきたした急性呼吸不全の一例, Ohshimo S, 第36回 日本呼吸療法医学会学術総会, 2014/07, With Invitation
  29. Angiopoietin-2 Gene Polymorphism as Prognostic Factor in Caucasians with Idiopathic Pulmonary Fibrosis, Shinichiro Ohshimo, Yasushi Horimasu, Francesco Bonella, Hiroshi Iwamoto, Nobuhisa Ishikawa, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Josune Guzman, Ulrich Costabel, Nobuoki Kohno, European Respiratory Society International Congress 2014, 2014/09, Without Invitation
  30. Decreased circulatory receptor for advanced glycation end-products is associated with poorer survival in patients with idiopathic pulmonary fibrosis, Hiroshi Iwamoto, Yasushi Horimasu, Taku Nakashima, Tadashi Senoo, Shinichiro Ohshimo, Nobuhisa Ishikawa, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Witold Mazur, Nobuoki Kohno, European Respiratory Society International Congress 2014, 2014/09, Without Invitation
  31. Annual changes in pulmonary function is an independent prognostic factor for the patients with chronic hypersensitivity pneumonia, Yasushi Horimasu, Nobuhisa Ishikawa, Taku Nakashima, Hiroshi Iwamoto, Tadashi Senoo, Shinichiro Ohshimo, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Nobuoki Kohno, European Respiratory Society International Congress 2014, 2014/09, Without Invitation
  32. Potential value of KL-6 in various interstitial lung diseases, Shinichiro Ohshimo, European Respiratory Society International Congress 2014, 2014/09, With Invitation
  33. GAP Index as a predictor of acute exacerbation in idiopathic pulmonary fibrosis, Shinichiro Ohshimo, Yasushi Horimasu, Francesco, Bonella, Chihiro Yamaoka, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Hironobu Hamada, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Josune Guzman, Ulrich Costabel, Nobuoki Kohno, The 3rd combined WASOG and BAL Meeting, 2014/10, Without Invitation
  34. ドクターヘリ広域連携 消防・防災ヘリとの連携による効果, 大谷直嗣, 宇根一暢,太田浩平,山賀聡之,鈴木慶,大下慎一郎,津村龍,岩崎泰昌,廣橋伸之,山野上敬夫,谷川攻一, 第42回 日本救急医学会総会・学術集会, 2014/10, Without Invitation
  35. 脂肪塞栓症候群によるARDSに対しV-V ECMOを導入し救命した一例, 島谷竜俊, 山賀聡之, 矢野佳子, 田邉優子, 太田浩平, 宇根一暢, 大下慎一郎, 岩崎泰昌, 廣橋伸之, 谷川攻一, 第42回 日本救急医学会総会・学術集会, 2014/10, Without Invitation
  36. 広島大学病院高度救命救急センターにおける自殺企図者の実態について, 岩崎泰昌, 大下慎一郎, 大谷直嗣, 宇根一暢, 太田浩平, 山賀聡之, 木田佳子, 津村 龍, 廣橋伸之, 吉野敦雄, 谷川攻一, 第42回 日本救急医学会総会・学術集会, 2014/10, Without Invitation
  37. 切除不能肺腺癌における予後予測マーカーとしての血清KL-6の有用性, 堀益 靖, 服部 登, 益田 武, 中島 拓, 岩本博志, 妹尾 直, 大下慎一郎, 石川暢久, 藤高一慶, 春田吉則, 村井 博, 宮田義浩, 岡田守人, 濱田泰伸, 河野修興, 第55回 日本肺癌学会学術集会, 2014/11, Without Invitation
  38. Risk factors for severe anaphylaxis presenting prolonged hypotension, Satoshi Yamaga, Shinichiro Ohshimo, Satoshi Morioke, Tatsutoshi Shimatani, Michihito Kyo, Hiroshi Giga, Kazuhiro Koyama, Takahiro Inagawa, Kei Suzuki, Yoshiko Kida, Kohei Ota, Yuko Tanabe, Kazunobu Une, Tadatsugu Otani, Takuma Sadamori, Ryu Tsumura, Yasumasa Iwasaki, Nobuyuki Hirohashi, Michihiro Hide, Koichi Tanigawa, American Heart Association 2014, 2014/11, Without Invitation, Chicago, IL
  39. Usefulness of ECMO for acute exacerbation of interstitial pneumonia, Ohshimo S, The 31st Annual Meeting of the Japanese Society for Therapeutics Engineering, 2014/12/05, Without Invitation, Hiroshima
  40. 広島県のヘリコプター救急医療体制 ドクターヘリ広域連携・消防防災ヘリとの連携, Otani T, 鈴木慶、木田佳子、山賀聡之、田邉優子、太田浩平、田村朋子、宇根一暢、貞森拓磨、大下慎一郎、津村龍、岩崎泰昌、廣橋伸之、板井純治、佐伯辰彦、多田昌弘、竹崎亨、楠真二、山野上敬夫、谷川攻一, 日本医工学治療学会第31回学術大会, 2014/12/05, Without Invitation, Hiroshima
  41. 救急・集中治療領域における呼吸管理, Hirohashi N, Ohshimo S, Tanigawa K, 日本医工学治療学会第31回学術大会, 2014/12/05, With Invitation
  42. Prognostic indicators for patients with acute respiratory failure treated with high-frequency oscillatory ventilation, Yuko Tanabe, Shinichiro Ohshimo, Yoshiko Kida, Kei Suzuki, Satoshi Yamaga, Kohei Ota, Kazunobu Une, Koichi Tanigawa, Annual Congress 44th Critical Care Congress, 2015/01, Without Invitation, Phoenix, Arizona, USA
  43. Correlation of intracellular histamine and clinical symptoms in anaphylactic patients, Satoshi Yamaga, Satoshi Morioke, Shinichiro Ohshimo, Kei Suzuki, Yasumasa Iwasaki, Nobuyuki Hirohashi, Michihiro Hide, Koichi Tanigawa, Annual Congress 44th Critical Care Congress, 2015/01, Without Invitation, Phoenix, Arizona, USA
  44. アナフィラキシーにおける凝固異常の検討, 山賀聡之, 大下慎一郎,木田佳子, 太田浩平,大谷直嗣,宇根一暢,岩崎泰昌,廣橋伸之,秀道広,谷川攻一, 第42回日本集中治療医学会学術集会, 2015/02, Without Invitation, Tokyo, Japan
  45. 非HIV患者の重症ニューモシスチス肺炎に対する体外式膜型人工肺の有用性, 太田浩平, 大下慎一郎,木田佳子,山賀聡之,鈴木慶,稲川嵩紘,宇根一暢,岩崎泰昌,廣橋伸之,谷川攻一, 第42回日本集中治療医学会学術集会, 2015/02, Without Invitation, Tokyo, Japan
  46. ECMOを成功させるためには:ECMO有効活用へ向けた当院の取り組み, 大下慎一郎, 第42回日本集中治療医学会学術集会, 2015/02, With Invitation, Tokyo, Japan
  47. 間質性肺炎急性増悪におけるECMOの有用性, 木田佳子, 大下慎一郎,太田浩平,山賀聡史,鈴木慶、岩崎泰昌,廣橋伸之,谷川攻一, 第42回日本集中治療医学会学術集会, 2015/02, Without Invitation, Tokyo, Japan
  48. 敗血症診断におけるPresepsinの有用性の検討, 鈴木 慶, 大下 慎一郎, 京 道人, 小山 和宏, 田邊 優子, 稲川 嵩紘, 太田 浩平, 岩崎 泰昌, 廣橋 伸之, 谷川 攻一, 第42回日本集中治療医学会学術集会, 2015/02, Without Invitation, Tokyo, Japan
  49. 間質性肺炎急性増悪における体外式膜型人工肺(ECMO)の有用性, Ohshimo S, 日本医工学治療学会第31回学術大会, 2015/03/27, Without Invitation, Hiroshima
  50. KL-6 changes in serum could predict the development of chronic lung allograft dysfunction in lung transplant recipients, V. Besa, F. Bonella , S. Ohshimo, G. Weinreich , U.Costabel, M. Kamler, H. Teschler, U. Sommerwerck, ISHLT 35th Annual Meeting and Scientific Sessions, 2015/04, Without Invitation, Nice, France
  51. Growth differentiation factor-15 (GDF-15) as prognostic factor in Caucasians with idiopathic pulmonary fibrosis, Ohshimo S, Hamai K, Bonella F, Yamaoka C, Horimasu Y, Iwamoto H, Ishikawa N, Fujitaka K, Murai H, Hamada H, Hattori N, Hirohashi N, Tanigawa K, Guzman J, Costabel U, Kohno N., 第55回日本呼吸器学会学術講演会, 2015/04, Without Invitation, Tokyo, Japan
  52. HRCT findings as a predictive dactor for acute exacerbation of idiopathic pulmonary fibrosis., Yamaoka C, Horimasu Y, Iwamoto H, Ohshimo S, Fujitaka K, Hattori N, Hamada H, Kohno N., 第55回日本呼吸器学会学術講演会, 2015/04, Without Invitation, Tokyo, Japan
  53. Growth Differentiation Factor-15 (GDF-15) as Prognostic Factor in German Patients with Idiopathic Pulmonary Fibrosis, Ohshimo S, American Thoracic Society 2015 International Conference, 2015/05, Without Invitation, Denver, CO
  54. Serum KL-6 levels correlate with response to pirfenidone in idiopathic pulmonary fibrosis, F. Bonella, S. Ohshimo, E. Boerner, J. Guzman, T.E. Wessendorf, U. Costabel, American Thoracic Society 2015 International Conference, 2015/05, Without Invitation, Denver, CO
  55. 複数傷病者事案に対するヘリコプター救急医療活動について, 大谷直嗣, 鈴木慶、山賀聡之、田村朋子、太田浩平、大下慎一郎、津村龍、岩崎泰昌、廣橋伸之、板井純治、多田昌弘、竹崎亨、楠真二、山野上敬夫、谷川攻一, 第31回日本救急医学会 中国四国地方会, 2015/05, Without Invitation, Tokushima, Japan
  56. Benefit of veno-venous ECMO in patients with acute exacerbation of interstitial pneumonia, Ohshimo S, Asia-Pacific ELSO 2015 - 2nd Conference of Asia-Pacific Chapter of Extracorporeal Life Support Organization, 2015/07, Without Invitation, Kyoto, Japan
  57. Analysis of autopsy findings in patients with acute respiratory failure supported on V-V ECMO, Kida Y, Shinichiro Ohshimo, Kohei Ota, Kei Suzuki, Satoshi Yamaga, Yasumasa Iwasaki, Nobuyuki Hirohashi, Koichi Tanigawa, Asia-Pacific ELSO 2015 - 2nd Conference of Asia-Pacific Chapter of Extracorporeal Life Support Organization, 2015/07, Without Invitation, Kyoto, Japan
  58. Successful use of V-VA ECMO in a patient with respiratory failure complicated by myocarditis, Kyo M, Shinichiro Ohshimo, Yoshiko Kida, Kohei Ota, Kei Suzuki, Satoshi Yamaga, Yasumasa Iwasaki, Nobuyuki Hirohashi, Koichi Tanigawa, Asia-Pacific ELSO 2015 - 2nd Conference of Asia-Pacific Chapter of Extracorporeal Life Support Organization, 2015/07, Without Invitation, Kyoto, Japan
  59. 心筋炎に伴う呼吸不全に対してV-VA ECMOを施行した一例, 京 道人, 大下慎一郎,儀賀普嗣,島谷竜俊,小山和宏,稲川嵩紘,鈴木 慶,矢野佳子,山賀聡之,田邉優子,太田浩平,宇根一暢,大谷直嗣,貞森拓磨,津村 龍,岩崎泰昌,廣橋伸之,谷川攻一, 第37回日本呼吸療法医学会総会, 2015/07, Without Invitation, Tokyo, Japan
  60. 日本人の間質性肺炎急性増悪症例における体外式膜型人工肺(ECMO)の有用性, 大下慎一郎, 木田佳子, 太田浩平, 京 道人, 島谷竜俊, 儀賀普嗣, 小山和宏, 稲川嵩紘, 鈴木 慶, 山賀聡之, 田邉優子, 大谷直嗣, 貞森拓磨, 宇根一暢, 津村 龍, 岩崎泰昌, 廣橋伸之, 服部 登, 河野修興, 谷川攻一, 第37回日本呼吸療法医学会総会, 2015/07, Without Invitation, Tokyo, Japan
  61. ARDSの疫学:患者の生命予後は改善されたのか?, 大下慎一郎, 第37回日本呼吸療法医学会総会, 2015/07, With Invitation, Tokyo, Japan
  62. V-V ECMOを使用した成人急性呼吸不全症例における剖検診断の検討, 木田佳子, 大下慎一郎, 太田浩平, 山賀聡之, 鈴木慶, 田邉優子, 稲川嵩紘, 小山和宏, 儀賀普嗣, 京道人, 島谷竜俊, 宇根一暢, 大谷直嗣, 岩崎泰昌, 廣橋伸之, 河野修興, 谷川攻一, 第37回日本呼吸療法医学会総会, 2015/07, Without Invitation, Tokyo, Japan
  63. Comparative Analysis of Multiple Gene Polymorphisms for Acute Exacerbation of Idiopathic Pulmonary Fibrosis, Ohshimo S, European Respiratory Society (ERS) International Congress 2015, 2015/09, Without Invitation, Amsterdam, Netherlands
  64. Serum KL-6 as a biomarker to assess response to azathioprine in connective tissue disease associated lung disease (CTD-ILD), Boerner EB, Wessendorf TE, Ohshimo S, Costabel U, Bonella F., European Respiratory Society International Congress 2015, 2015/09, Without Invitation, Amsterdam, Netherlands
  65. MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma, Horimasu Y, Ishikawa N, Tanaka S, Iwamoto H, Ohshimo S, Fujitaka K, Hattori N, Hamada H, Kohno N., European Respiratory Society International Congress 2015, 2015/09, Without Invitation, Amsterdam, Netherlands
  66. 嘔吐マネキンモデルに対する 救急救命士による気管挿管における Airway ScopeとMacintosh型喉頭鏡の比較, 鈴木 慶, 楠 真二,貞森 拓磨,田邊 優子,板井純治,大下慎一郎,廣橋伸之,志馬伸朗, 第43回 日本救急医学会総会・学術集会, 2015/10, Without Invitation, Tokyo, Japan
  67. シアン化カリウムによる急性中毒を救命し得た1症例, 田邉優子, 山賀聡之,佐藤智人,稲川嵩紘,鈴木慶,矢野佳子,太田浩平,大谷直嗣,大下慎一郎,岩崎泰昌,廣橋伸之, 第43回 日本救急医学会総会・学術集会, 2015/10, Without Invitation, Tokyo, Japan
  68. 災害現場での無人航空機(ドローン)による映像伝送の有用性, 島谷竜俊, 貞森拓磨、鈴木慶、木田佳子、山賀聡之、太田浩平、田邉優子、大谷直嗣、大下慎一郎、岩崎泰昌、廣橋伸之, 第43回 日本救急医学会総会・学術集会, 2015/10, Without Invitation, Tokyo, Japan
  69. ヘリコプター2機による連携で対応した複数傷病者の一事案, 鳥越勇佑, 大谷直嗣, 京道人, 島谷竜俊, 鈴木慶, 山賀聡之, 太田浩平, 大下慎一郎, 津村龍, 岩崎泰昌, 廣橋伸之, 儀賀普嗣, 多田昌弘, 竹崎亨, 山野上敬夫, 第22回日本航空医療学会総会, 2015/11, Without Invitation, 前橋,群馬
  70. 救命救急センターにおける黄色ブドウ球菌菌血症の予後関連因子についての検討, 京 道人, 木田佳子, 大下慎一郎, 廣橋伸之, 志馬伸朗, 第38回広島感染症研究会, 2015/11/07, Without Invitation, Hiroshima
  71. 集中治療室における黄色ブドウ球菌敗血症患者の予後因子, 京 道人, 木田 佳子、大下 慎一郎、鈴木 慶、山賀 聡之、廣橋 伸之、志馬 伸朗, 第43回日本集中治療医学会学術集会, 2016/02, Without Invitation, Kobe, Japan
  72. 呼吸音自動解析能を有する新たな電子聴診器の開発, 山賀聡之, 大下慎一郎,貞森拓磨,儀賀普嗣,岩崎泰昌,廣橋伸之,志馬伸朗, 第43回日本集中治療医学会学術集会, 2016/02, Without Invitation, Kobe, Japan
  73. ECMO使用患者における予後因子としての赤血球分布幅, 大下慎一郎, 木田佳子, 京 道人,島谷竜俊,鳥越勇佑,鈴木 慶,山賀聡之,岩崎泰昌,廣橋伸之,志馬伸朗, 第43回日本集中治療医学会学術集会, 2016/02, Without Invitation, Kobe, Japan
  74. 人工呼吸器離脱にNAVAが有用であった2症例, 木田佳子, 大下慎一郎,志馬伸朗, 第43回日本集中治療医学会学術集会 NAVAミーティング, 2016/02/12, Without Invitation, Nagoya, Japan
  75. マムシ咬傷により発症した破傷風の一例, 岡崎裕介, 山賀聡之, 島谷竜俊, 京道人, 小山和宏, 稲川嵩紘, 鳥越勇佑, 鈴木慶, 木田佳子, 田邉優子, 太田浩平, 大谷直嗣, 貞森拓磨, 津村龍, 大下慎一郎, 岩崎泰昌, 廣橋伸之, 志馬伸朗, 第33回日本集中治療医学会 中国四国地方会, 2016/02/20, Without Invitation, Hiroshima, Japan
  76. FAM13A polymorphism as a prognostic factor in Japanese patients with idiopathic pulmonary fibrosis, Hirano C, Ohshimo S, Horimasu Y, Iwamoto H, Hamada H, Hattori N, Bonella F, Guzman J, Costabel U, Kohno N., 2016/04, Without Invitation, Kyoto, Japan
  77. FAM13A polymorphism as a prognostic factor in Japanese patients with idiopathic pulmonary fibrosis, Hirano C, Ohshimo S, Horimasu Y, Iwamoto H, Fujitaka K, Hamada H, Hattori N, Bonella F, Guzman J, Costabel U, Kohno N., American Thoracic Society International Conference 2016, 2016/05, Without Invitation, San Francisco, CA
  78. ARDSシンポジウム, 大下慎一郎, 第38回 日本呼吸療法医学会学術集会, 2016/07, With Invitation, Nagoya, Japan
  79. Detection of anti DFS70 antibodies in patients with interstitial lung disease (ILD) with and without connective tissue disease (CTD), Bonella F, Lyu Y, Theegarten D, Boerner E, Wessendorf TE, Ohshimo S, Guzman J, Costabel U, Kreuter M., ERS International Congress, 2016/09, Without Invitation, London, UK
  80. The experiences of physical therapy for the patients with veno-venous extracorporeal membrane oxygenation in Hiroshima university hospital, SARADA K, TAITO S, SEKIKAWA K, OHSHIMO S, OTA K, HIROHASHI N, UEDA K, MIKAMI Y, KIMURA H, SHIME N, ITO Y, 13th Asian Confederation of Physical Therapy: ACPT Congress 2016, 2016/10, Without Invitation
  81. Analysis of autopsy findings in patients with acute respiratory failure supported on V-V ECMO, Yoshiko Kida, Shinichiro Ohshimo, Michihito Kyo, Tatutoshi Shimatani, Nobuyuki Hirohashi, Nobuaki Shime, The 35th Annual Conference of the Korean Society of Critical Care Medicine, 2016/04, Without Invitation
  82. Successful use of VAV ECMO in a patient with respiratory failure complicated by myocarditis, Michihito Kyo, Shinichiro Ohshimo, Yoshiko Kida, Tatsutoshi Shimatani, Yusuke Torikoshi, Kei Suzuki, Satoshi Yamaga, Nobuyuki Hirohashi, Nobuaki Shime, The 35th Annual Conference of the Korean Society of Critical Care Medicine, 2016/04, Without Invitation
  83. Optimal Volume and Substance in Intraesophageal Balloon Catheter for Esophageal Pressure Measurement, Tatsutoshi Shimatani, Shinichiro Ohshimo, Michihito Kyo, Yoshiko Kida, Nobuaki Shime, The 35th Annual Conference of the Korean Society of Critical Care Medicine, 2016/04, Without Invitation
  84. Prognostic factors for critically ill patients with Staphylococcus aureus bacteremia, 大下 慎一郎, 木田 佳子, 島谷 竜俊, 鳥越 勇佑, 鈴木 慶, 山賀 聡之, 廣橋 伸之, 志馬 伸朗, 2016/07, Without Invitation
  85. The utilization of information and communication technology in the acute phase of Kumamoto earthquake, 2016/10, Without Invitation
  86. Red cell distribution width as a prognostic factor for patients supported with ECMO, 2016/02, Without Invitation
  87. Protein expression profile in acute exacerbation of interstitial pneumonia supported on V-V ECMO, Yoshiko Kida, Shinichiro Ohshimo, Michihito Kyo, AMATYA Jeet Vishwa, Yukio Takeshima, Nobuaki Shime, Annual Congress 46th Critical Care Congress, 2017/01, Without Invitation, Honolulu, Hawaii, USA
  88. The validation of qSOFA criteria for sepsis, Michihito Kyo, Shinichiro Ohshimo, Yoshiko Kida, Nobuaki Shime, Annual Congress 46th Critical Care Congress, 2017/01, Without Invitation, Honolulu, Hawaii, USA
  89. Effect of Electrical Cardioversion for New-Onset Atrial Fibrillation in Intensive Care Unit, 2017/03, Without Invitation
  90. Extracorporeal membrane oxygenation for 2016 influenza-associated acute respiratory failure in Japan, Shinichiro Ohshimo, Nobuaki Shime, Satoshi Nakagawa, Osamu Nishida, Shinhiro Takeda; Committee of Japan ECMO project, Asia-Pacific ELSO Conference 2017, 2017/10, With Invitation
  91. Association between survival rates and detailed underlying diseases in patients who underwent ECMO: Report from the Japanese Registry of Respiratory ECMO, Toshiyuki Aokage1, Yuji Fujino2, Shinichiro Ohshimo3, Osamu Nishida4, Shinhiro Takeda5, Kenichi Matsuda6; Committee of ECMO project, Asia-Pacific ELSO Conference 2017, 2017/10, Without Invitation
  92. Exposure and ILD: Exploring novel therapy, Shinichiro Ohshimo, Asia-Pacific Regional Conference 2017, 2017/03/24, With Invitation
  93. Helicobacter pylori as a risk factor for acute exacerbation in idiopathic pulmonary fibrosis, Shinichiro Ohshimo 1, Hiromi Nishi 2, Yasushi Horimasu 3, Hiroshi Iwamoto 3, Hironobu Hamada 3, Noboru Hattori 3, Nobuoki Kohno 3 , Francesco Bonella 4, Josune Guzman 5, Ulrich Costabel 4, Nobuaki Shime 1, American Thoracic Society 2017 International Conference, 2017/05, Without Invitation
  94. Accuracy of a Clinical Diagnosis of Idiopathic Pulmonary Fibrosis: A Study of 275 Pulmonologists from 54 Countries, Simon L.F. Walsh, David Hansell , Kevin R. Flaherty , Margaret Wilsher , Richard Nusser , Venerino Poletti , Fernando J. Martinez , Elisabeth Bendstrup , Kevin K. Brown , Hiroyuki Taniguchi , Yasuhiro Kondoh , Bruno Crestani , Vincent Cottin , Dominique Valeyre , Hilario Nunes , Jan C. Grutters , Luca Richeldi , Toby M. Maher , Carlo Vancheri , Maria Kokosi , Christopher J. Ryerson , Kerri A. Johannson , Brett J. Ley , Eoin P. Judge , George Margaritopoulos , Michael Kreuter , Juergen Behr , António Morais , Marlies Wijsenbeek , Tamera J. Corte , Ian Glaspole , Paolo Spagnolo , Sara Tomassetti , Maria Molina-Molina , Moises Selman , Vasilis Kouranos , Wim A. Wuyts , Mark Jones , Athol U. Wells; the IPF project (Shinichiro Ohshimo), American Thoracic Society 2017 International Conference, 2017/05, Without Invitation
  95. Agreement between pulmonologists for the diagnosis of interstitial lung disease: a study of 275 pulmonologists from 54 countries, Simon L.F. Walsh, David Hansell , Kevin R. Flaherty , Margaret Wilsher , Richard Nusser , Venerino Poletti , Fernando J. Martinez , Elisabeth Bendstrup , Kevin K. Brown , Hiroyuki Taniguchi , Yasuhiro Kondoh , Bruno Crestani , Vincent Cottin , Dominique Valeyre , Hilario Nunes , Jan C. Grutters , Luca Richeldi , Toby M. Maher , Carlo Vancheri , Maria Kokosi , Christopher J. Ryerson , Kerri A. Johannson , Brett J. Ley , Eoin P. Judge , George Margaritopoulos , Michael Kreuter , Juergen Behr , António Morais , Marlies Wijsenbeek , Tamera J. Corte , Ian Glaspole , Paolo Spagnolo , Sara Tomassetti , Maria Molina-Molina , Moises Selman , Vasilis Kouranos , Wim A. Wuyts , Mark Jones , Athol U. Wells; the IPF project (Shinichiro Ohshimo), American Thoracic Society 2017 International Conference, 2017/05, Without Invitation
  96. Accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: A study of 404 pulmonologists from 57 countries., Simon Walsh, David Hansell, Toby Maher, Richard Nusser, Margaret Wilsher, Venerino Poletti, Carlo Vancheri, Luca Richeldi, Paolo Spagnolo, Sara Tomassetti, Vincent Cottin, Bruno Crestani, Dominiue Valeyre, Hilario Nunes, Kevin Brown, Brett Ley, Fernando Martinez, Ganesh Raghu, Kevin Flaherty, Jan C. Grutters, Marlies Wijsenbeek, Hiroyuki Taniguchi, Yoshikazu Inoue, Yasuhiro Kondoh, Moises Selman, Tamera Corte, Ian Glaspole, Martin Kolb, Kerri Johannson, Chris Ryerson, Elisabeth Bendstrup, António Morais, Maria Molina Molina, Wim Wuyts, Juergen Behr, Michael Kreuter, Katerina Antoniou, Athol Wells, George Margaritopoulos, Maria Kokosi, Vasilis Kouranos, Eoin Judge; the IPF project (Shinichiro Ohshimo), European Respiratory Society (ERS) International Congress 2017, 2017/09, Without Invitation
  97. Agreement between pulmonologists for the diagnosis of interstitial lung disease: a study of 404 pulmonologists from 57 countries., Simon Walsh, David Hansell, Toby Maher, Richard Nusser, Margaret Wilsher, Venerino Poletti, Carlo Vancheri, Luca Richeldi, Paolo Spagnolo, Sara Tomassetti, Vincent Cottin, Bruno Crestani, Dominiue Valeyre, Hilario Nunes, Kevin Brown, Brett Ley, Fernando Martinez, Ganesh Raghu, Kevin Flaherty, Jan C. Grutters, Marlies Wijsenbeek, Hiroyuki Taniguchi, Yoshikazu Inoue, Yasuhiro Kondoh, Moises Selman, Tamera Corte, Ian Glaspole, Martin Kolb, Kerri Johannson, Chris Ryerson, Elisabeth Bendstrup, António Morais, Maria Molina Molina, Wim Wuyts, Juergen Behr, Michael Kreuter, Katerina Antoniou, Athol Wells, George Margaritopoulos, Maria Kokosi, Vasilis Kouranos, Eoin Judge; the IPF project (Shinichiro Ohshimo), European Respiratory Society (ERS) International Congress 2017, 2017/09, Without Invitation
  98. Extracorporeal membrane oxygenation for the treatment of acute exacerbation of interstitial lung diseases, Shinichiro Ohshimo1,2, Yoshiko Kida1, Michihito Kyo1, Yasushi Horimasu2, Hiroshi Iwamoto2, Kazunori Fujitaka2, Hironobu Hamada2, Francesco Bonella3, Josune Guzman4, Ulrich Costabel3, Nobuaki Shime1, Noboru Hattori2, European Respiratory Society (ERS) International Congress 2017, 2017/09, Without Invitation
  99. Impact of Inappropriate Empiric Antibiotic Therapy on Mortality in Pediatric Patients with Bloodstream Infection, Michihito Kyo1, Shinichiro Ohshimo1, Tadashi Kosaka2, Naohisa Fujita2 and Nobuaki Shime1, The 30th International Congress of Chemotherapy and Infection 2017, 2017/11, Without Invitation
  100. How to develop the ARDS clinical practice guideline 2016, Shinichiro Ohshimo, Minds 20th Clinical practice guideline workshop, 2017/08/26, With Invitation
  101. Acute respiratory failure in ILD: diagnosis and management, Shinichiro Ohshimo, WASOG 2017 International conference on Sarcoidosis and Interstitial Lung Diseases (ILD), 2017/10, With Invitation
  102. ECMO, Shinichiro Ohshimo, The 11th forum of diffuse lung diseases, 2017/12/16, With Invitation
  103. Respiratory management in ICU & Emergency department: (1) Mechanical ventilation in the new era, Shinichiro Ohshimo, The 33rd Annual Meeting of the Japanese Society for Therapeutics & Engineering, 2017/04, With Invitation
  104. Respiratory management in ICU & Emergency department: (1) Management of acute respiratory failure using extracorporeal membrane oxygenation, Shinichiro Ohshimo, The 33rd Annual Meeting of the Japanese Society for Therapeutics & Engineering, 2017/04, With Invitation
  105. Utility of electronic stethoscope in remote areas medical, Giga H, Ishitoya K, Sadamori T, Kikutani K, Shimatani T, Ohshimo S, Shime N, Japanese Telemedicine and Telecare Association 2017, 2017/09, Without Invitation
  106. A case of Capnocytophaga infections complicated with purpura fulminans and disseminated intravascular coagulation, Yusuke Okazaki, Yoshiko Kida, Yuko Tanabe, Kei Suzuki, Shinichiro Ohshimo, Nobuaki Shime, 2017/11, Without Invitation
  107. Corticosteroids are not always useful for ARDS, Shinichiro Ohshimo, The 45th Annual Meeting of the Japanese Association for Acute Medicine, 2017/10, With Invitation
  108. Utility of intracellular histamine concentration in anaphylaxis, The 45th Annual Meeting of the Japanese Association for Acute Medicine, 2017/10, Without Invitation
  109. Ground-glass opacity and fibrosis on HRCT as risk factors of acute exacerbation of IPF: an international multicenter study, Chihiro Hirano, Shinichiro Ohshimo1, Hilmar Kuehl2, Daisuke Komoto3, Yasushi Horimasu1, Hiroshi Iwamoto1, Hironobu Hamada1, Noboru Hattori1, Ulrich Costabel4, Nobuoki Kohno1, The 57th Annual Meeting of the Japanese Respiratory Society, 2017/04, Without Invitation
  110. Bronchoalveolar lavage as a diagnostic and prognostic tool in acute respiratory failure, Yusuke Iwasaki, Yoshiko Kida, Michihito Kyo, Koji Hosokawa, Shinichiro Ohshimo, Nobuaki Shime, ISICEM 2018-38th International Symposium on Intensive Care and Emergency Medicine, 2018/03, Without Invitation
  111. Changes in end-of-life practices (EOLP) in European intensive care units (ICUs): The Ethicus study, C.L. Sprung, C. Hartog, B. Ricou, A. Michalsen, C. Feldman, P. Levin, M. Baras, M. Weiss, HH. Buelow, A. Avian for the Ethicus II investigators (Shinichiro Ohshimo), ISICEM 2018-38th International Symposium on Intensive Care and Emergency Medicine, 2018/03, Without Invitation
  112. End-of-life practices (EOLP) in worldwide intensive care units (ICUs): The Ethicus study, A. Avidan, C.L. Sprung, B. Ricou, A. Michalsen, C. Feldman, M. Anstey, M. Baras, M. Weiss, HH. Buelow, C. Hartog for the Ethicus II investigators (Shinichiro Ohshimo), ISICEM 2018-38th International Symposium on Intensive Care and Emergency Medicine, 2018/03, Without Invitation
  113. Emerging ventilation strategy during cardiopulmonary resuscitation, Shinichiro Ohshimo, The 45th Annual Meeting of the Japanese Society of Intensive Care Medicine, 2018/02, With Invitation
  114. Update in the prevention and the diagnosis of ventilator-associated pneumonia, Shinichiro Ohshimo, The 45th Annual Meeting of the Japanese Society of Intensive Care Medicine, 2018/02, With Invitation
  115. Rhabdomyolysis induced by hyperthermia associated with thermoregulatory failure in a patient with spinal cord injury, Junki Ishii, Yoshiko Kida, Shinichiro Ohshimo, Yuki Uchida, Yusuke Iwasaki, Kazuhiro Koyama, Satoshi Yamaga, Kohei Ota, Nobuaki Shime, The 18th Joint Scientific Congress of the JSICM and KSCCM, 2018/02, Without Invitation

Awards

  1. 2014年10月08日, Best Presentation Award, World Association for Sarcoidosis and Other Granulomatous Disorders, GAP index as a predictor of acute exacerbation in idiopathic pulmonary fibrosis
  2. 2017年04月13日, Researcher of Excellence, Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology (PARDIE) Study
  3. 2018年07月11日, Featured Research, Journal of Intensive Care, Comparison of extracorporeal membrane oxygenation outcome for influenza-associated acute respiratory failure in Japan between 2009 and 2016

Patented

  1. Patent, JP第2370816号, 2014/04/30, METHOD FOR DIAGNOSIS OF CYSTIC FIBROSIS USING KL-6 LEVELS
  2. Patent, ドイツ602009023757.8号, 2014/04/30, METHOD FOR DIAGNOSIS OF CYSTIC FIBROSIS USING KL-6 LEVELS
  3. Patent, Supporting structure of sensor grip in electronic stethoscope
  4. Patent, Analyzer,methodology and computer-assisted program for respiratory sounds

External Funds

Acceptance Results of Competitive Funds

  1. KAKENHI, 2013, 2015
  2. KAKENHI, 2013, 2016
  3. 文部科学省科学研究費助成金, 間質性肺炎急性増悪の人種差および好中球転写因子を用いた多角的病態解明と治療開発, 2016, 2018
  4. KAKENHI, 2016, 2018
  5. Japan Agency for Medical Research and Development, 2017, 2020
  6. 2017, 2017
  7. 2017, 2017
  8. 2017, 2017
  9. 2017, 2017
  10. 2017, 2020
  11. 2017, 2019

Social Activities

History as Committee Members

  1. Guideline Committee for Acute Respiratory Distress Syndrome, 2014/04, Japanese Society of Intensive Care Medicine, Japanese Society of Respiratory Care Medicine
  2. Guideline Committee for High-Frequency Oscillatory Ventilation, 2014, Japanese Society of Respiratory Care Medicine
  3. Task Force for Chronic Hypersensitivity Pneumonia, 2014, European Respiratory Society
  4. Crisis-management Committee, 2015, Japanese Society of Respiratory Care Medicine
  5. Councilor, 2009, Japanese Society of Internal Medicine
  6. 委員, 2015/04
  7. 厚生労働省難病医療費助成制度 難病指定医, 2015
  8. 日本医師会認定産業医, 2015

History as Peer Reviews of Academic Papers

  1. 2014, Lab Invest, Reviewer, 1
  2. 2014, BMC Pulm Med, Reviewer, 2
  3. 2014, iConcept Press, Reviewer, 1
  4. 2014, Respir Res, Reviewer, 1
  5. 2014, Arch Med Res, Reviewer, 1
  6. 2013, Case Rep Pulm, Reviewer, 2
  7. 2015, Clinical Medicine Insights, Reviewer, 5
  8. 2015, Pediat Int, Reviewer, 1
  9. 2015, Inflammation, Reviewer, 1
  10. 2014, Intern Med, Reviewer, 1
  11. 2015, Dove Medical Press, Reviewer, 1
  12. 2011, Respir Care, Reviewer, 1
  13. 2013, Sarcoidosis vasculitis and diffuse lung diseases, Reviewer, 1
  14. 2015, 集中治療会誌, Reviewer, 1
  15. 2013, Eur Respir J, Reviewer, 1
  16. 2015, Intern Med, Reviewer, 1
  17. 2016, J Intensiv Care, Reviewer, 2
  18. 2016, Respir Med, Reviewer, 3
  19. 2016, Eur Respir Mon, Reviewer, 1
  20. 2016, J Anesthesisa, Reviewer, 2
  21. 2016, Rheumatology, Reviewer, 1
  22. 2016, PLoS ONE, Reviewer, 1
  23. 2016, J Artif Organ, Reviewer, 2
  24. 2016, J intensive Care, Reviewer, 5
  25. 2016, Respir Investig, Reviewer, 1
  26. 2016, Infectious Disorders - Drug Targets, Reviewer, 1
  27. 2016, BMC Pulm Med, Reviewer, 2
  28. 2016, Pediat Crit Care Med, Reviewer, 1
  29. 2016, Respir Med, Reviewer, 3